PMA device
Flow FL-100
Flow Neuroscience AB · Cranial Electrotherapy Stimulator To Treat Depression (JXK, Class III) · First FDA decision Dec 8, 2025, newest Dec 8, 2025Depression
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "Flow FL-100"
MAUDE reports
0
Brand "Flow FL-100", since 2015
PubMed studies
0
Mentioning "Flow FL-100"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Flow FL-100BreakthroughPMA
P230024 · Decided Dec 8, 2025 · 854 days after receipt
Device type: Cranial electrotherapy stimulator to treat depression (JXK) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Vagus Nerve Stimulation for Treatment of Resistant Depression (TRD)National analysisReview closedCAG-00313RUpdated Sep 24, 2026
- Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression (TRD)National analysisReview closedCAG-00313R2Updated Sep 24, 2026
- Electrotherapy for Treatment of Facial Nerve Paralysis (Bell's Palsy)National determinationOn the books160.15Updated Apr 17, 2020
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34522First Coast Service Options, Inc.Updated Oct 21, 2022
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34998Novitas Solutions, Inc.Updated Oct 21, 2022
Clinical trials
Device studies on ClinicalTrials.gov that name "Flow FL-100", any status and sponsor, newest update first.
- A Study of Home-use Brain Stimulation to Treat Bipolar DepressionPivotal-lookingRecruiting
King's College LondonAcademic, hospital or other
NCT07556692 · 212 participants (planned) · Start Apr 24, 2026 · Primary completion Apr 30, 2027
Device: Flow FL-100 tDCS headset · For: Bipolar Disorder (BD)
Sites: London, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Flow FL-100", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code JXK
6 reports: 0 malfunction, 5 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Flow FL-100"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code JXK.
- ProlivRx SystemNeurolief , Ltd. · PMA 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.